TY - JOUR
AU - Eleni Domzaridou
AU - Matthew J. Carr
AU - Tim Millar
AU - Roger T. Webb
AU - Darren M. Ashcroft
A1 - 
AD - National Institute for Health and Care Research Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom eleni.domzaridou@manchester.ac.uk; Centre for Mental Health and Safety, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom ; Domzaridou, Eleni,Manchester,United Kingdom,M13 9PL,Centre for Pharmacoepidemiology and Drug Safety, University of Manchester,eleni.domzaridou@manchester.ac.uk
BT - Addiction
C5 - Opioids & Substance Use
CP - 12
DB - APA PsycInfo®
DO - 10.1111/add.16306
IS - 12
JF - Addiction
LA - English
PY - 2023
SN - 0965-2140, 0965-2140
SP - 2374
EP - 2383+
ST - Non‐fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
T1 - Non‐fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
T2 - Addiction
TI - Non‐fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
U1 - Opioids & Substance Use
U3 - 10.1111/add.16306
VL - 118
VO - 0965-2140, 0965-2140
Y1 - 2023
ER -